IBDEI0DY ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,6412,0)
 ;;=N18.2^^30^392^14
 ;;^UTILITY(U,$J,358.3,6412,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6412,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 2
 ;;^UTILITY(U,$J,358.3,6412,1,4,0)
 ;;=4^N18.2
 ;;^UTILITY(U,$J,358.3,6412,2)
 ;;=^5015603
 ;;^UTILITY(U,$J,358.3,6413,0)
 ;;=N18.3^^30^392^15
 ;;^UTILITY(U,$J,358.3,6413,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6413,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 3
 ;;^UTILITY(U,$J,358.3,6413,1,4,0)
 ;;=4^N18.3
 ;;^UTILITY(U,$J,358.3,6413,2)
 ;;=^5015604
 ;;^UTILITY(U,$J,358.3,6414,0)
 ;;=N18.4^^30^392^16
 ;;^UTILITY(U,$J,358.3,6414,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6414,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 4
 ;;^UTILITY(U,$J,358.3,6414,1,4,0)
 ;;=4^N18.4
 ;;^UTILITY(U,$J,358.3,6414,2)
 ;;=^5015605
 ;;^UTILITY(U,$J,358.3,6415,0)
 ;;=N18.5^^30^392^17
 ;;^UTILITY(U,$J,358.3,6415,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6415,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 5
 ;;^UTILITY(U,$J,358.3,6415,1,4,0)
 ;;=4^N18.5
 ;;^UTILITY(U,$J,358.3,6415,2)
 ;;=^5015606
 ;;^UTILITY(U,$J,358.3,6416,0)
 ;;=Q61.3^^30^392^86
 ;;^UTILITY(U,$J,358.3,6416,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6416,1,3,0)
 ;;=3^Polycystic Kidney,Unspec
 ;;^UTILITY(U,$J,358.3,6416,1,4,0)
 ;;=4^Q61.3
 ;;^UTILITY(U,$J,358.3,6416,2)
 ;;=^5018797
 ;;^UTILITY(U,$J,358.3,6417,0)
 ;;=N20.1^^30^392^9
 ;;^UTILITY(U,$J,358.3,6417,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6417,1,3,0)
 ;;=3^Calculus Ureter
 ;;^UTILITY(U,$J,358.3,6417,1,4,0)
 ;;=4^N20.1
 ;;^UTILITY(U,$J,358.3,6417,2)
 ;;=^5015608
 ;;^UTILITY(U,$J,358.3,6418,0)
 ;;=N18.9^^30^392^18
 ;;^UTILITY(U,$J,358.3,6418,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6418,1,3,0)
 ;;=3^Chronic Kidney Failure,Unspec
 ;;^UTILITY(U,$J,358.3,6418,1,4,0)
 ;;=4^N18.9
 ;;^UTILITY(U,$J,358.3,6418,2)
 ;;=^332812
 ;;^UTILITY(U,$J,358.3,6419,0)
 ;;=N18.6^^30^392^32
 ;;^UTILITY(U,$J,358.3,6419,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6419,1,3,0)
 ;;=3^End Stage Renal Disease (ESRD)
 ;;^UTILITY(U,$J,358.3,6419,1,4,0)
 ;;=4^N18.6
 ;;^UTILITY(U,$J,358.3,6419,2)
 ;;=^303986
 ;;^UTILITY(U,$J,358.3,6420,0)
 ;;=N52.9^^30^392^48
 ;;^UTILITY(U,$J,358.3,6420,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6420,1,3,0)
 ;;=3^Erectile Dysfunction,Unspec
 ;;^UTILITY(U,$J,358.3,6420,1,4,0)
 ;;=4^N52.9
 ;;^UTILITY(U,$J,358.3,6420,2)
 ;;=^5015763
 ;;^UTILITY(U,$J,358.3,6421,0)
 ;;=N32.81^^30^392^81
 ;;^UTILITY(U,$J,358.3,6421,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6421,1,3,0)
 ;;=3^Overactive Bladder
 ;;^UTILITY(U,$J,358.3,6421,1,4,0)
 ;;=4^N32.81
 ;;^UTILITY(U,$J,358.3,6421,2)
 ;;=^5015652
 ;;^UTILITY(U,$J,358.3,6422,0)
 ;;=Q61.2^^30^392^85
 ;;^UTILITY(U,$J,358.3,6422,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6422,1,3,0)
 ;;=3^Polycystic Kidney,Adult Type
 ;;^UTILITY(U,$J,358.3,6422,1,4,0)
 ;;=4^Q61.2
 ;;^UTILITY(U,$J,358.3,6422,2)
 ;;=^5018796
 ;;^UTILITY(U,$J,358.3,6423,0)
 ;;=N41.1^^30^392^89
 ;;^UTILITY(U,$J,358.3,6423,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6423,1,3,0)
 ;;=3^Prostatitis,Chronic
 ;;^UTILITY(U,$J,358.3,6423,1,4,0)
 ;;=4^N41.1
 ;;^UTILITY(U,$J,358.3,6423,2)
 ;;=^186931
 ;;^UTILITY(U,$J,358.3,6424,0)
 ;;=N11.9^^30^392^97
 ;;^UTILITY(U,$J,358.3,6424,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6424,1,3,0)
 ;;=3^Pyelonephritis,Chronic,Unspec
 ;;^UTILITY(U,$J,358.3,6424,1,4,0)
 ;;=4^N11.9
 ;;^UTILITY(U,$J,358.3,6424,2)
 ;;=^5015574
 ;;^UTILITY(U,$J,358.3,6425,0)
 ;;=N20.9^^30^392^108
 ;;^UTILITY(U,$J,358.3,6425,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6425,1,3,0)
 ;;=3^Urinary Calculus,Unspec
